{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T16:40:37Z","timestamp":1739119237735,"version":"3.37.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,9]]},"DOI":"10.7759\/cureus.78773","type":"journal-article","created":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T16:05:51Z","timestamp":1739117151000},"source":"Crossref","is-referenced-by-count":0,"title":["Progressive Cutaneous Cholesterol Emboli Syndrome"],"prefix":"10.7759","author":[{"given":"Elizabeth S","family":"Szumel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel A","family":"Mickel-Hulse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Contarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.886465","article-title":"Cholesterol embolization syndrome","volume":"122","author":"Kronzon I","year":"2010","unstructured":"Kronzon I, Saric M. Cholesterol embolization syndrome. Circulation. 2010, 122:631-41. 10.1161\/CIRCULATIONAHA.109.886465","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202301316R","article-title":"Pathophysiology and targeted treatment of cholesterol crystal embolism and the related thrombotic angiopathy","volume":"37","author":"Shi C","year":"2023","unstructured":"Shi C, Mammadova-Bach E, Li C, Liu D, Anders HJ. Pathophysiology and targeted treatment of cholesterol crystal embolism and the related thrombotic angiopathy. FASEB J. 2023, 37:e23179. 10.1096\/fj.202301316R","journal-title":"FASEB J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/11.8.1607","article-title":"Cholesterol atheromatous embolism: an increasingly recognized cause of acute renal failure","volume":"11","author":"Scolari F","year":"1996","unstructured":"Scolari F, Bracchi M, Valzorio B, et al.. Cholesterol atheromatous embolism: an increasingly recognized cause of acute renal failure. Nephrol Dial Transplant. 1996, 11:1607-12. 10.1093\/ndt\/11.8.1607","journal-title":"Nephrol Dial Transplant"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(02)02870-9","article-title":"Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque","volume":"90","author":"Tunick PA","year":"2002","unstructured":"Tunick PA, Nayar AC, Goodkin GM, et al.. Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque. Am J Cardiol. 2002, 90:1320-5. 10.1016\/s0002-9149(02)02870-9","journal-title":"Am J Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2004.06.036","article-title":"The role of aortic stent grafting in the treatment of atheromatous embolization syndrome: results after a mean of 15 months follow-up","volume":"40","author":"Carroccio A","year":"2004","unstructured":"Carroccio A, Olin JW, Ellozy SH, et al.. The role of aortic stent grafting in the treatment of atheromatous embolization syndrome: results after a mean of 15 months follow-up. J Vasc Surg. 2004, 40:424-9. 10.1016\/j.jvs.2004.06.036","journal-title":"J Vasc Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(03)00579-5","article-title":"The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study","volume":"42","author":"Fukumoto Y","year":"2003","unstructured":"Fukumoto Y, Tsutsui H, Tsuchihashi M, Masumoto A, Takeshita A. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol. 2003, 42:211-6. 10.1016\/s0735-1097(03)00579-5","journal-title":"J Am Coll Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.52.3.339","article-title":"Cholesterol embolism as a complication of left heart catheterisation. Report of seven cases","volume":"52","author":"Drost H","year":"1984","unstructured":"Drost H, Buis B, Haan D, Hillers JA. Cholesterol embolism as a complication of left heart catheterisation. Report of seven cases. Br Heart J. 1984, 52:339-42. 10.1136\/hrt.52.3.339","journal-title":"Br Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-013-0315-y","article-title":"The cholesterol emboli syndrome in atherosclerosis","volume":"15","author":"Quinones A","year":"2013","unstructured":"Quinones A, Saric M. The cholesterol emboli syndrome in atherosclerosis. Curr Atheroscler Rep. 2013, 15:315. 10.1007\/s11883-013-0315-y","journal-title":"Curr Atheroscler Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2023-257927","article-title":"Blue toe syndrome caused by cholesterol crystal embolisation in a patient with warfarin use","volume":"16","author":"Kano Y","year":"2023","unstructured":"Kano Y, Shigehara Y. Blue toe syndrome caused by cholesterol crystal embolisation in a patient with warfarin use. BMJ Case Rep. 2023, 16:e257927. 10.1136\/bcr-2023-257927","journal-title":"BMJ Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2023.101780","article-title":"Spontaneous cholesterol embolism leading to small bowel obstruction and perforation","volume":"13","author":"Mahtani AU","year":"2023","unstructured":"Mahtani AU, Tahir MK, Padda I, Haider M, Ebrahimi F, Otterbeck P, Nfonoyim J. Spontaneous cholesterol embolism leading to small bowel obstruction and perforation. JACC Case Rep. 2023, 13:101780. 10.1016\/j.jaccas.2023.101780","journal-title":"JACC Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v10.i25.9162","article-title":"Idiopathic cholesterol crystal embolism with atheroembolic renal disease and blue toes syndrome: a case report","volume":"10","author":"Cheng DJ","year":"2022","unstructured":"Cheng DJ, Li L, Zheng XY, Tang SF. Idiopathic cholesterol crystal embolism with atheroembolic renal disease and blue toes syndrome: a case report. World J Clin Cases. 2022, 10:9162-7. 10.12998\/wjcc.v10.i25.9162","journal-title":"World J Clin Cases"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/iju5.12631","article-title":"Partial penectomy for severe penile ulceration caused by cholesterol crystal embolization","volume":"6","author":"Matsushima T","year":"2023","unstructured":"Matsushima T, Mitsunari K, Maekawa N, et al.. Partial penectomy for severe penile ulceration caused by cholesterol crystal embolization. IJU Case Rep. 2023, 6:394-7. 10.1002\/iju5.12631","journal-title":"IJU Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/000331970505600420","article-title":"Cholesterol embolization treated with corticosteroids--two case reports","volume":"56","author":"Koga J","year":"2005","unstructured":"Koga J, Ohno M, Okamoto K, et al.. Cholesterol embolization treated with corticosteroids--two case reports. Angiology. 2005, 56:497-501. 10.1177\/000331970505600420","journal-title":"Angiology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-005-0012-4","article-title":"Cholesterol crystal embolization mimicking vasculitis: success with corticosteroid and cyclophosphamide therapy in two cases","volume":"26","author":"Y\u00fccel AE","year":"2006","unstructured":"Y\u00fccel AE, Kart-K\u00f6seoglu H, Demirhan B, Ozdemir FN. Cholesterol crystal embolization mimicking vasculitis: success with corticosteroid and cyclophosphamide therapy in two cases. Rheumatol Int. 2006, 26:454-60. 10.1007\/s00296-005-0012-4","journal-title":"Rheumatol Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2005.tb00766.x","article-title":"Cholesterol crystal embolization: skin manifestation, gastrointestinal and central nervous symptom treated with corticosteroid","volume":"32","author":"Motegi S","year":"2005","unstructured":"Motegi S, Abe M, Shimizu A, et al.. Cholesterol crystal embolization: skin manifestation, gastrointestinal and central nervous symptom treated with corticosteroid. J Dermatol. 2005, 32:295-8. 10.1111\/j.1346-8138.2005.tb00766.x","journal-title":"J Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-7061(01)02183-5","article-title":"Treatment of atheroembolization with corticosteroids","volume":"14","author":"Mann SJ","year":"2001","unstructured":"Mann SJ, Sos TA. Treatment of atheroembolization with corticosteroids. Am J Hypertens. 2001, 14:831-4. 10.1016\/s0895-7061(01)02183-5","journal-title":"Am J Hypertens"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12530","article-title":"Painful macules of hand cholesterol crystal embolization successfully treated with oral corticosteroid, statin, and sarpogrelate","volume":"41","author":"Kusakari Y","year":"2014","unstructured":"Kusakari Y, Yamasaki K, Aiba S. Painful macules of hand cholesterol crystal embolization successfully treated with oral corticosteroid, statin, and sarpogrelate. J Dermatol. 2014, 41:662-4. 10.1111\/1346-8138.12530","journal-title":"J Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s101570300010","article-title":"Acute renal failure due to cholesterol crystal embolism treated with LDL apheresis followed by corticosteroid and candesartan","volume":"7","author":"Tamura K","year":"2003","unstructured":"Tamura K, Umemura M, Yano H, et al.. Acute renal failure due to cholesterol crystal embolism treated with LDL apheresis followed by corticosteroid and candesartan. Clin Exp Nephrol. 2003, 7:67-71. 10.1007\/s101570300010","journal-title":"Clin Exp Nephrol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.324.7332.268","article-title":"Improvement in cholesterol emboli syndrome after iloprost therapy","volume":"324","author":"Elinav E","year":"2002","unstructured":"Elinav E, Chajek-Shaul T, Stern M. Improvement in cholesterol emboli syndrome after iloprost therapy. BMJ. 2002, 324:268-9. 10.1136\/bmj.324.7332.268","journal-title":"BMJ"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-0968.2003.00081.x","article-title":"Apheresis in the treatment of cholesterol embolic disease","volume":"7","author":"Hasegawa M","year":"2003","unstructured":"Hasegawa M, Sugiyama S. Apheresis in the treatment of cholesterol embolic disease. Ther Apher Dial. 2003, 7:435-8. 10.1046\/j.1526-0968.2003.00081.x","journal-title":"Ther Apher Dial"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/s0741-5214(05)80008-4","article-title":"Surgical management of atheroembolization","volume":"21","author":"Keen RR","year":"1995","unstructured":"Keen RR, McCarthy WJ, Shireman PK, Feinglass J, Pearce WH, Durham JR, Yao JS. Surgical management of atheroembolization. J Vasc Surg. 1995, 21:773-80; discussion 780-1. 10.1016\/s0741-5214(05)80008-4","journal-title":"J Vasc Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/328815-progressive-cutaneous-cholesterol-emboli-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T16:05:52Z","timestamp":1739117152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/328815-progressive-cutaneous-cholesterol-emboli-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,9]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.78773","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,9]]}}}